Bellevue Life Sciences Acquisition Corp. announced a private placement to issue unsecured promissory note for gross proceeds of $60,000 on March 8, 2024. The transaction included participation from Josh Pan.

The promissory note is not interest bearing and is payable in full on the earlier of August 8, 2024 or the date on which the company consummates an initial business combination.